title: Cytoskeletal dynamics in rabbit synovial fibroblasts: I. Effects of acrylamide on intermediate filaments and microfilaments.
abstract: Rabbit synovial fibroblasts respond to changes in cell shape and cytoskeletal architecture by altering specific gene expression. We have tested the ability of acrylamide, a neurotoxin that alters the distribution of intermediate filaments in cultured PtK1 cells, to induce metalloprotease expression in synovial fibroblasts. Cells treated with 2-20 mM acrylamide for 5 to 24 h underwent shape changes similar to cells treated with the tumor promoter phorbol myristate acetate. Intermediate filaments visualized with anti-vimentin antibodies did not collapse into a perinuclear cap in these rounded cells, but were still present in the extended cell processes. Unexpectedly, when actin was visualized in acrylamide-treated cells, extensive dissociation and clumping of microfilaments was observed. Concentrations of acrylamide greater than 10 mM were cytotoxic, but cells recovered completely after 24 h incubation with 5 mM acrylamide. Like other agents that alter cell shape and actin distribution in synovial fibroblasts, acrylamide also induced expression of the secreted metalloprotease collagenase. Although some recent evidence suggests that acrylamide may be able to exert its collagenase-inducing effects extracellularly, perhaps through transmembrane matrix receptors, our observation that this neurotoxin dramatically alters protein synthesis in synovial fibroblasts suggests that direct effects on cell metabolism may also play a role in acute acrylamide intoxication.
authors.affiliation: Department of Human Anatomy, School of Medicine, University of California, Davis 95616.
authors.forename: J
authors.initials: J
authors.lastname: Aggeler
authors.forename: K
authors.initials: K
authors.lastname: Seely
mesh_terms: D020106:Acrylamide; D000178:Acrylamides / Q000494:pharmacology*; D008841:Actin Cytoskeleton / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D000199:Actins / Q000378:metabolism / Q000648:ultrastructure; D000818:Animals; D002478:Cells, Cultured; D017364:Collagenases; D003599:Cytoskeleton / Q000187:drug effects*; D004591:Electrophoresis, Polyacrylamide Gel; D004790:Enzyme Induction / Q000187:drug effects; D004792:Enzyme Precursors / Q000096:biosynthesis / Q000378:metabolism; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D007382:Intermediate Filaments / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D008666:Metalloendopeptidases / Q000096:biosynthesis; D003012:Microbial Collagenase / Q000096:biosynthesis / Q000378:metabolism; D008856:Microscopy, Fluorescence; D011817:Rabbits; D013582:Synovial Fluid / Q000166:cytology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014746:Vimentin / Q000276:immunology
chemical_list: D000178:Acrylamides; D000199:Actins; D004792:Enzyme Precursors; D014746:Vimentin; D020106:Acrylamide; D017364:Collagenases; D008666:Metalloendopeptidases; C022440:procollagenase; D003012:Microbial Collagenase; D013755:Tetradecanoylphorbol Acetate